2015
DOI: 10.1016/j.ijso.2016.02.004
|View full text |Cite
|
Sign up to set email alerts
|

A comparison of the usage of anal verge and dentate line in measuring distances within the rectum

Abstract: Introduction: The anal verge is key in determining measurement-based suitability for neoadjuvant radiotherapy in rectal cancer. The dentate line is a distinct anatomic landmark and may permit more accurate measurement for rectal lesions. This study aimed to establish measurative ranges for distances of the rectal valves from the dentate line and the anal verge and to compare variability between the two. Methods: Patients (n = 104) undergoing colonoscopy… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 12 publications
0
2
0
Order By: Relevance
“…Additionally, exible scopes lack centimeter markings for measurements. However, a standardized approach to measurement, as previously reported, was taken for all patients [37]. Furthermore, from a practical standpoint, an analysis using exible as opposed to rigid endoscopy, may be more relevant as it is thought to be increasingly replaced by exible sigmoidoscopy in clinical practice [38].…”
Section: Discussionmentioning
confidence: 99%
“…Additionally, exible scopes lack centimeter markings for measurements. However, a standardized approach to measurement, as previously reported, was taken for all patients [37]. Furthermore, from a practical standpoint, an analysis using exible as opposed to rigid endoscopy, may be more relevant as it is thought to be increasingly replaced by exible sigmoidoscopy in clinical practice [38].…”
Section: Discussionmentioning
confidence: 99%
“…The inclusion criteria were: 1) histologically confirmed rectal adenocarcinoma with biopsy sample, 2) clinical stage T3 to T4 or any stage T and N + tumors without distant metastasis (based on the 7th edition of the American Joint Committee on Cancer), 3) an Eastern Cooperative Oncology Group (ECOG) performance status of 0–1 without any severe complications, 4) tumors invading the internal and/or external anal sphincter determined by pre-treatment MRI examination, 5) the lower edge of tumors had been assessed by pre-treatment endoscopy [ 18 ], and 6) patients who had undergone neoadjuvant long-course chemoradiation followed by TME. The exclusion criteria were: 1) occurrence of distant failure before surgery, 2) unsuitability for radical surgery by clinical examination and imaging, 3) history of pelvic radiation, 4) secondary malignancies, 5) incomplete clinical or pathological data, 6) NCRT or surgery in another hospital, and 7) previous recurrent rectal cancer.…”
Section: Methodsmentioning
confidence: 99%